Revenue
attach_money12M USD
YoY +73.4%
PRLDPrelude Therapeutics Incorporated$ --
Prelude Therapeutics Incorporated
PRLD
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 12/31/2025
Operating Income
bar_chart-105M USD
YoY +25.2%
Net Income
verified-99M USD
YoY +21.8%
EPS
pie_chart-1.29USD
YoY +23.2%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress103.4%On Track
Revenue Progress12.1M
Revenue Forecast17.5M
Net Income Progress-99.5M
Net Income Forecast-96.2M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.